RIGL - Rigel Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts7777
Avg. Estimate-0.130.08-0.28-0.39
Low Estimate-0.150-0.37-0.45
High Estimate-0.120.13-0.22-0.28
Year Ago EPS-0.140.03-0.44-0.28
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts6666
Avg. Estimate11.78M50.63M84.94M81.67M
Low Estimate10.38M38.12M73.65M52M
High Estimate12.5M54.44M89.88M103.07M
Year Ago SalesN/A37.86M44.51M84.94M
Sales Growth (year/est)N/A33.70%90.80%-3.80%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.150.03-0.13-0.14
EPS Actual-0.140.03-0.11-0.12
Difference0.0100.020.02
Surprise %6.70%0.00%15.40%14.30%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.130.08-0.28-0.39
7 Days Ago-0.130.08-0.28-0.39
30 Days Ago-0.140.08-0.29-0.35
60 Days Ago-0.140.07-0.31-0.36
90 Days Ago-0.140.07-0.31-0.36
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days1221
Up Last 30 Days3442
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1N/AN/AN/A
Growth EstimatesRIGLIndustrySectorS&P 500
Current Qtr.7.10%N/AN/A-0.00
Next Qtr.166.70%N/AN/A0.08
Current Year36.40%N/AN/A0.03
Next Year-39.30%N/AN/A0.10
Next 5 Years (per annum)70.00%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A